BackTable / Innovation / Podcast / Episode #12

Raising Capital

with Dr. Orrin Ailloni-Charas

We talk with anesthesiologist and venture capitalist Dr. Orrin Ailloni-Charas about the mechanics of fundraising from both the entrepreneur and the investor side.

Raising Capital with Dr. Orrin Ailloni-Charas on the BackTable Innovation Podcast)
Ep 12 Raising Capital with Dr. Orrin Ailloni-Charas
00:00 / 01:04

BackTable, LLC (Producer). (2021, December 10). Ep. 12 – Raising Capital [Audio podcast]. Retrieved from https://www.backtable.com

BackTable CMEfy button

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Orrin Ailloni-Charas discusses Raising Capital on the BackTable 12 Podcast

Dr. Orrin Ailloni-Charas

Dr. Orrin Ailloni-Charas is the founder and managing partner at Cura Capital in San Francisco, California.

Dr. Bryan Hartley discusses Raising Capital on the BackTable 12 Podcast

Dr. Bryan Hartley

Dr. Bryan Hartley is a practicing radiologist, host of the BackTable Innovation series, and co-founder of Pulmera in Palo Alto, CA.

Show Notes

In this episode, anesthesiologist and venture capitalist Dr. Orrin Ailloni-Charas joins our host Dr. Bryan Hartley to discuss the mechanics of fundraising from both the entrepreneur and the investor side.

First, they talk about the definition of venture capitalism (VC) and its impact on GDP. Dr. Ailloni-Charas notes that the only way to get true and sustainable growth is through innovation of new products, opportunities, and industries. These efforts rely on VC for support. On a macro-level, new technologies require large investments in order to accelerate to the market. On a micro-level, each company also needs investment and guidance.

Dr. Aillioni-Charas walks through different stages of fundraising rounds: friends/family, seed, Series A, Series B, and so on. He says that each round should be centered around a milestone goal that advances the company closer to the final product and exit strategy. He also emphasizes the importance of storytelling and communicating product-market fit and uniqueness to potential investors.

From an investor standpoint, Dr. Aillioni-Charas highlights “green flags” and “red flags” that he has seen in startups. Positive factors are the presence of true clinical need, the ability to receive constructive feedback, and establishment functional oversight boards. Finally, we talk about the valuable clinical perspective that doctors can bring to a company and pathways that doctors can get involved in angel and VC investing.

Resources

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Earn CME When You Listen to BackTable CMEfy

Up Next

Patient Preparation Made Easy: The Wellprept Story with Dr. David Canes on the BackTable Innovation Podcast)
Punishing the Machine and Treating Autism: Sirica Therapeutics Dr. Uli Chettipally on the BackTable Innovation Podcast)
From Weird to Wonderful: An Interview with Theator Founder Dr. Tamir Wolf with Dr. Tamir Wolf on the BackTable Innovation Podcast)
Investing in Yourself, Sobtech & the Evolution of AI in Teleradiology with Dr. Vikram Sobti on the BackTable Innovation Podcast)
Host Stories with Dr. Bryan Hartley and Dr. Eric Gantwerker on the BackTable Innovation Podcast)
Intelligent Ignorance: Turning Ideas into Innovation with Dr. Matthew Bromwich on the BackTable Innovation Podcast)

Articles

Topics

Learn about Fundraising on BackTable Innovation
Learn about Innovation on BackTable Innovation
Learn about Venture Capital on BackTable Innovation

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.